vs
Ceribell, Inc.(CBLL)与electroCore, Inc.(ECOR)财务数据对比。点击上方公司名可切换其他公司
Ceribell, Inc.的季度营收约是electroCore, Inc.的2.7倍($24.8M vs $9.2M)。electroCore, Inc.净利率更高(-32.8% vs -54.6%,领先21.7%)
Ceribell, Inc.是一家专注于神经诊断领域的医疗科技企业,主打便携式快速脑电图检测设备,可为急症、重症护理场景提供便捷的癫痫发作监测解决方案,核心市场覆盖北美地区,目前正逐步推进全球化业务布局。
electroCore是一家总部位于美国新泽西州巴斯金里奇的医疗科技公司,于2005年由四位联合创始人创立,现任首席执行官为Daniel S. Goldberger。公司主打产品为gammaCore,是一款已实现商业化的非侵入式设备,通过迷走神经刺激发挥作用。
CBLL vs ECOR — 直观对比
营收规模更大
CBLL
是对方的2.7倍
$9.2M
净利率更高
ECOR
高出21.7%
-54.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $24.8M | $9.2M |
| 净利润 | $-13.5M | $-3.0M |
| 毛利率 | 87.3% | 88.4% |
| 营业利润率 | -58.9% | -31.8% |
| 净利率 | -54.6% | -32.8% |
| 营收同比 | — | 31.2% |
| 净利润同比 | — | 6.0% |
| 每股收益(稀释后) | $-0.35 | $-0.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CBLL
ECOR
| Q4 25 | $24.8M | $9.2M | ||
| Q3 25 | $22.6M | $8.7M | ||
| Q2 25 | $21.2M | $7.4M | ||
| Q1 25 | $20.5M | $6.7M | ||
| Q4 24 | — | $7.0M | ||
| Q3 24 | $17.2M | $6.6M | ||
| Q2 24 | — | $6.1M | ||
| Q1 24 | — | $5.4M |
净利润
CBLL
ECOR
| Q4 25 | $-13.5M | $-3.0M | ||
| Q3 25 | $-13.5M | $-3.4M | ||
| Q2 25 | $-13.6M | $-3.7M | ||
| Q1 25 | $-12.8M | $-3.9M | ||
| Q4 24 | — | $-3.2M | ||
| Q3 24 | $-10.4M | $-2.5M | ||
| Q2 24 | — | $-2.7M | ||
| Q1 24 | — | $-3.5M |
毛利率
CBLL
ECOR
| Q4 25 | 87.3% | 88.4% | ||
| Q3 25 | 88.3% | 86.0% | ||
| Q2 25 | 88.1% | 87.3% | ||
| Q1 25 | 87.9% | 84.9% | ||
| Q4 24 | — | 85.9% | ||
| Q3 24 | 87.3% | 83.8% | ||
| Q2 24 | — | 86.3% | ||
| Q1 24 | — | 83.7% |
营业利润率
CBLL
ECOR
| Q4 25 | -58.9% | -31.8% | ||
| Q3 25 | -64.8% | -33.2% | ||
| Q2 25 | -70.5% | -47.5% | ||
| Q1 25 | -69.3% | -56.9% | ||
| Q4 24 | — | -43.6% | ||
| Q3 24 | -57.8% | -40.4% | ||
| Q2 24 | — | -42.2% | ||
| Q1 24 | — | -70.7% |
净利率
CBLL
ECOR
| Q4 25 | -54.6% | -32.8% | ||
| Q3 25 | -59.6% | -39.2% | ||
| Q2 25 | -64.4% | -49.7% | ||
| Q1 25 | -62.4% | -57.4% | ||
| Q4 24 | — | -45.8% | ||
| Q3 24 | -60.6% | -38.1% | ||
| Q2 24 | — | -43.2% | ||
| Q1 24 | — | -64.4% |
每股收益(稀释后)
CBLL
ECOR
| Q4 25 | $-0.35 | $-0.34 | ||
| Q3 25 | $-0.37 | $-0.40 | ||
| Q2 25 | $-0.38 | $-0.44 | ||
| Q1 25 | $-0.36 | $-0.47 | ||
| Q4 24 | — | $-0.37 | ||
| Q3 24 | $-1.85 | $-0.31 | ||
| Q2 24 | — | $-0.38 | ||
| Q1 24 | — | $-0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $159.3M | $11.6M |
| 总债务越低越好 | — | $7.8M |
| 股东权益账面价值 | $155.3M | $-1.7M |
| 总资产 | $195.8M | $18.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CBLL
ECOR
| Q4 25 | $159.3M | $11.6M | ||
| Q3 25 | $168.5M | $13.0M | ||
| Q2 25 | $177.4M | $7.1M | ||
| Q1 25 | $182.7M | $7.8M | ||
| Q4 24 | — | $12.2M | ||
| Q3 24 | $14.1M | $12.9M | ||
| Q2 24 | — | $14.2M | ||
| Q1 24 | — | $7.8M |
总债务
CBLL
ECOR
| Q4 25 | — | $7.8M | ||
| Q3 25 | — | $7.8M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
CBLL
ECOR
| Q4 25 | $155.3M | $-1.7M | ||
| Q3 25 | $164.1M | $-1.1M | ||
| Q2 25 | $172.2M | $1.1M | ||
| Q1 25 | $180.9M | $4.4M | ||
| Q4 24 | — | $7.5M | ||
| Q3 24 | $-136.0M | $9.5M | ||
| Q2 24 | — | $11.5M | ||
| Q1 24 | — | $4.5M |
总资产
CBLL
ECOR
| Q4 25 | $195.8M | $18.7M | ||
| Q3 25 | $199.5M | $21.4M | ||
| Q2 25 | $207.7M | $14.6M | ||
| Q1 25 | $213.5M | $16.0M | ||
| Q4 24 | — | $20.5M | ||
| Q3 24 | $47.1M | $21.0M | ||
| Q2 24 | — | $22.4M | ||
| Q1 24 | — | $13.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-10.8M | $-1.5M |
| 自由现金流经营现金流 - 资本支出 | $-11.0M | — |
| 自由现金流率自由现金流/营收 | -44.2% | — |
| 资本支出强度资本支出/营收 | 0.7% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-41.6M | — |
8季度趋势,按日历期对齐
经营现金流
CBLL
ECOR
| Q4 25 | $-10.8M | $-1.5M | ||
| Q3 25 | $-11.1M | $-1.7M | ||
| Q2 25 | $-7.5M | $-623.0K | ||
| Q1 25 | $-11.4M | $-4.4M | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $-1.8M | ||
| Q1 24 | — | $-2.6M |
自由现金流
CBLL
ECOR
| Q4 25 | $-11.0M | — | ||
| Q3 25 | $-11.5M | $-1.7M | ||
| Q2 25 | $-7.6M | $-648.0K | ||
| Q1 25 | $-11.6M | $-4.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率
CBLL
ECOR
| Q4 25 | -44.2% | — | ||
| Q3 25 | -50.8% | -19.3% | ||
| Q2 25 | -35.9% | -8.8% | ||
| Q1 25 | -56.4% | -65.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度
CBLL
ECOR
| Q4 25 | 0.7% | 0.0% | ||
| Q3 25 | 1.6% | 0.0% | ||
| Q2 25 | 0.3% | 0.3% | ||
| Q1 25 | 0.7% | 0.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
ECOR
暂无分部数据